EUVIMED · CrossrefZeitschrift
Journal of Law and the Biosciences
ISSN 2053-9711 · Oxford University Press (OUP)
Neueste Artikel
Biobanks as fiduciaries of biosamples and data: a legal and ethical analysis in the light of international standards
Xenocortical mice: what can we learn, and how should this research progress?
The recognition pathway: reconceiving inventorship and obviousness for iterative CRISPR-AI convergence
Are human subjects in clinical trials fully protected in China? An empirical study of court judgments
The right to be human at work: why the GDPR and the AI act fail to protect workers’ inner lives
Disparities in access to gene therapy in the European Union: ethical and regulatory challenges
The future of AI regulation in drug development: a comparative analysis
Cross-border data sharing for research in Africa: an analysis of the data protection and research ethics requirements in 12 jurisdictions
Patient-centric federated learning: automating meaningful consent to health data sharing with smart contracts
A review of public comments submitted to the Centers for Medicare and Medicaid Services in response to the 2022 National Coverage Decision on treatment for Alzheimer’s disease
Neural personal information and its legal protection: evidence from China
Death and the artificial placenta
The new regulation of non-medical neurotechnologies in the European Union: overview and reflection
How AI challenges the medical device regulation: patient safety, benefits, and intended uses
The regulation of health data sharing in Africa: a comparative study
Certificates of confidentiality: privileging research data
Ethical, legal, and policy challenges in field-based neuroimaging research using emerging portable MRI technologies: guidance for investigators and for oversight
How penalizing substance use in pregnancy affects treatment and research: a qualitative examination of researchers’ perspectives
Neuroethics guidance documents: principles, analysis, and implementation strategies
The AI cycle of health inequity and digital ageism: mitigating biases through the EU regulatory framework on medical devices
Pathogen dematerialization and the ABS loophole
Is benefit sharing with research participants lawful in South Africa? An unexplored question in the governance of genomics research
Skating the line between general wellness products and regulated devices: strategies and implications
The international data governance landscape
Biomodifying the ‘natural’: from Adaptive Regulation to Adaptive Societal Governance
Examining the power of the social imaginary through competing narratives of data ownership in health research
Patient data ownership: who owns your health?
Four misconceptions about investigative genetic genealogy
China’s evolving biosafety/biosecurity legislations
Regulatory responses to medical machine learning
EUVIMED